Form 8-K NEOGENOMICS INC For: Oct 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Neogenomics (NEO) PT Raised to $22 at Craig-Hallum
October 30, 2018 4:00 PM EDTCraig-Hallum analyst Kevin Ellich raised the price target on Neogenomics (NASDAQ: NEO) to $22.00 while maintaining a Buy rating.
Ellich cited "excellent" Q3 results while the Genoptix deal ads another layer of growth.
... More
